- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00518141
Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART)
July 20, 2011 updated by: Sykehuset Telemark
Use of Acetylsalicylic Acid and Terbutalin in ART
This study aims to determine the possible effects of Acetyl Salicylic Acid (ASA) and Terbutalin on ART treatment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study aims to determine the possible effects of ASA and Terbutalin on ART treatment.
Study Type
Interventional
Enrollment (Actual)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Telemark
-
Porsgrunn, Telemark, Norway, 3901
- STHF, Kvinneklinikken, Fertilitetsklinikken Sor
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 39 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Infertile women below 39 years of age
Exclusion Criteria:
- Women who may react allergically to the drugs administered
- Women with hyperthyroid or IDDM
- Women who do not want to participate in the study
- Women who are unable to give informed, written consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
FER
|
ASA 75 mg, Terbutalin 5mg
|
No Intervention: 2
FER
|
|
Experimental: 3
SET
|
ASA 75 mg, Terbutalin 5mg
|
No Intervention: 4
SET
|
|
Experimental: 5
DET
|
ASA 75 mg, Terbutalin 5mg
|
No Intervention: 6
DET
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Pregnancy
Time Frame: 7 weeks
|
7 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jarl A Kahn, Dr. med, STHF, Kvinneklinikken, Fertilitetsklinikken Sor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2006
Primary Completion (Actual)
May 1, 2009
Study Completion (Actual)
May 1, 2009
Study Registration Dates
First Submitted
August 17, 2007
First Submitted That Met QC Criteria
August 17, 2007
First Posted (Estimate)
August 20, 2007
Study Record Updates
Last Update Posted (Estimate)
July 21, 2011
Last Update Submitted That Met QC Criteria
July 20, 2011
Last Verified
July 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Fibrinolytic Agents
- Fibrin Modulating Agents
- Platelet Aggregation Inhibitors
- Cyclooxygenase Inhibitors
- Antipyretics
- Dermatologic Agents
- Antifungal Agents
- Keratolytic Agents
- Aspirin
- Salicylic Acid
- Salicylates
Other Study ID Numbers
- S-06085 (REK)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Reproductive Techniques, Assisted
-
National Taiwan University HospitalUnknownReproductive Techniques, Assisted | Investigative Techniques | Reproductive TechniquesTaiwan
-
Merck KGaA, Darmstadt, GermanyMerck Serono GmbH, Germany; Merck B.V., Netherlands; Merck A.E., Greece; Merck... and other collaboratorsCompletedAssisted Reproductive Techniques | Reproductive Technology, AssistedItaly, Russian Federation, United Kingdom, Germany, Poland, Finland, Slovakia, Netherlands, Denmark, France, Greece
-
Tu Du HospitalFederico II University; University of Medicine and Pharmacy at Ho Chi Minh...Recruiting
-
Royan InstituteCompletedAssisted Reproductive TechniquesIran, Islamic Republic of
-
Instituto BernabeuUnknownReproductive Techniques, AssistedSpain
-
SEID S.A.RecruitingReproductive Techniques, AssistedSpain
-
Assistance Publique Hopitaux De MarseilleUnknownAssisted Reproductive TechniquesFrance
-
IVI BarcelonaCompletedReproductive Techniques, AssistedSpain
-
Instituto BernabeuUnknownReproductive Techniques, AssistedSpain
-
Cairo UniversityCompletedReproductive Techniques, Assisted
Clinical Trials on Acetyl Salicylic Acid and Terbutalin
-
Peking University First HospitalCompleted
-
St. Olavs HospitalRecruiting
-
Rigshospitalet, DenmarkCompletedBleeding | Thromboembolism
-
University of PortsmouthCompletedDiabetes Type 2United Kingdom
-
Rottapharm SpainCompletedCardiovascular DiseaseSpain
-
Rottapharm SpainCompletedCardiovascular DiseaseSpain
-
Pharmacoeconomic Unit, EgyptUnknownComplications Due to Heart Valve ProsthesisEgypt
-
Sanna SalmiUniversity of HelsinkiActive, not recruitingChronic Rhinosinusitis (Diagnosis)Finland
-
Aga Khan UniversityCompletedTooth Extraction Site HealingPakistan
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...CompletedChronic Arsenic PoisoningBangladesh